ReviewFrontiers in immunology2022

Long-term survival in extensive-stage small-cell lung cancer treated with different immune checkpoint inhibitors in multiple-line therapies: A case report and literature review.

Xu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.